Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shayegan Darou Afshan Pharmaceutical is a prominent Iranian pharmaceutical manufacturer dedicated to producing high-quality generic medicines. Established in 1995, the company operates advanced manufacturing facilities that comply with international Good Manufacturing Practice (GMP) standards. Its extensive product portfolio includes a variety of dosage forms such as tablets, capsules, syrups, and topical ointments. The company serves multiple therapeutic sectors, including cardiology, gastroenterology, neurology, and infectious diseases. Shayegan Darou Afshan focuses on enhancing domestic healthcare accessibility while exploring export opportunities in regional markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Darou Afshan Shayegan Pharmaceutical.